NEOADJUVANT

Clinical trials for NEOADJUVANT explained in plain language.

Never miss a new study

Get alerted when new NEOADJUVANT trials appear

Sign up with your email to follow new studies for NEOADJUVANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

New combo attack on tough sarcomas before surgery

Disease control Ongoing

This study is testing a new treatment approach for patients with certain soft tissue sarcomas. Before surgery, patients receive a combination of two immunotherapy drugs and a course of radiation therapy. The main goal is to see how much of the tumor is killed by this pre-surgery …

Matched conditions: NEOADJUVANT

Phase: PHASE2 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

NEOADJUVANT

Get alerted when new NEOADJUVANT trials appear

New combo attack on tough sarcomas before surgery